CLEARSIDE BIOMEDICAL, INC.

Profile

Company Names

CLEARSIDE BIOMEDICAL, INC.

Addresses

900 NORTH POINT PARKWAY, SUITE 200, ALPHARETTA, 2Q 30005

1220 OLD ALPHARETTA ROAD, SUITE 300, ALPHARETTA, GA 30005

1220 OLD ALPHARETTA RD, SUITE 300, ALPHARETTA, GA 30005

1220 ALPHARETTA RD., SUITE 300, ALPHARETTA, GA 30005

1220 OLD ALPHARETTA RD., SUITE 300, ALPHARETTA, GA 30005

212 RIVERGATE DRIVE, SUWANEE, GA 30024

Phone Numbers

678-270-3631
678-270-4005
678-428-7570

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, OTHER TECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$48,465,571.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2019-11-26 
$3,349,999.00 
$3,349,999.00 
$0.00 
Equity 
6
2016-09-28 
$320,009.00 
$320,009.00 
$0.00 
 
5
2015-11-23 
$14,449,993.00 
$20,000,000.00 
$5,550,007.00 
Equity 
4
2014-08-29 
$16,211,809.00 
$20,000,000.00 
$3,788,191.00 
Equity 
3
2014-04-28 
$2,999,997.00 
$6,000,000.00 
$3,000,003.00 
Debt 
2
2013-01-31 
$7,899,987.00 
$8,500,000.00 
$600,013.00 
Equity 
1
2012-01-03 
$3,233,777.00 
$4,000,000.00 
$766,223.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GERALD 
D. 
CAGLE 
DIRECTOR
COGNOPTIX, INC.   |  CLEARSIDE BIOMEDICAL, INC.
JERRY 
 
CAGLE 
DIRECTOR
CLEARSIDE BIOMEDICAL, INC.   |  PERFUSE THERAPEUTICS, INC.
GERALD 
D. 
CAGLE, PH.D. 
DIRECTOR
CLEARSIDE BIOMEDICAL, INC.
RICHARD 
 
CROARKIN 
DIRECTOR
CLEARSIDE BIOMEDICAL, INC.
CHARLES 
 
DEIGNAN 
EXECUTIVE OFFICER
CLEARSIDE BIOMEDICAL, INC.
CHARLES 
A. 
DEIGNAN 
EXECUTIVE OFFICER
CLEARSIDE BIOMEDICAL, INC.
CHARLIE 
 
DEIGNAN 
EXECUTIVE OFFICER
CLEARSIDE BIOMEDICAL, INC.
JEFFREY 
L. 
EDWARDS 
DIRECTOR
CLEARSIDE BIOMEDICAL, INC.
WILLIAM 
 
HUMPHRIES 
DIRECTOR
CLEARSIDE BIOMEDICAL, INC.   |  ACLARIS THERAPEUTICS, INC.   |  BRYN PHARMA, LLC
WILLIAM 
D. 
HUMPHRIES 
DIRECTOR
CLEARSIDE BIOMEDICAL, INC.   |  STRATA SKIN SCIENCES, INC.
GEORGE 
 
LASEZKAY 
EXECUTIVE OFFICER, DIRECTOR
RETROSENSE THERAPEUTICS, LLC   |  CLEARSIDE BIOMEDICAL, INC.
GLENN 
 
NORONHA 
EXECUTIVE OFFICER
CLEARSIDE BIOMEDICAL, INC.
MARK 
 
PRAUSNITZ 
DIRECTOR, PROMOTER
CLEARSIDE BIOMEDICAL, INC.   |  MICRON BIOMEDICAL, INC.   |  PIEZO THERAPEUTICS, INC.
CHRISTY 
 
SHAFFER 
DIRECTOR, PROMOTER
CLINIPACE INC   |  EVOAPP, INC.   |  CLEARSIDE BIOMEDICAL, INC.   |  G-ZERO THERAPEUTICS, INC.   |  G1 THERAPEUTICS, INC.   |  KINODYN, INC.   |  SPYRYX BIOSCIENCES, INC.   |  HATTERAS VENTURE PARTNERS V, LP   |  GRAYBUG, INC.   |  TREFOIL THERAPEUTICS, INC.   |  GRAYBUG VISION, INC.   |  ARTIZAN BIOSCIENCES, INC.   |  PERFUSE THERAPEUTICS, INC.   |  HATTERAS VENTURE PARTNERS VI, LP   |  AER THERAPEUTICS, INC.   |  HATTERAS VENTURE PARTNERS VII, LP   |  HATTERAS OPPORTUNITY FUND I, LP   |  HATTERAS CREATE SF SPV, LLC
CHRISTY 
L. 
SHAFFER 
DIRECTOR
CLEARSIDE BIOMEDICAL, INC.
CHRISTY 
L. 
SHAFFER, PH.D. 
DIRECTOR
CLEARSIDE BIOMEDICAL, INC.
CLAY 
 
THORP 
DIRECTOR
PHASEBIO PHARMACEUTICALS INC   |  CANCERGUIDE DIAGNOSTICS, INC.   |  PATHFINDER THERAPEUTICS, INC.   |  CLEARSIDE BIOMEDICAL, INC.   |  G-ZERO THERAPEUTICS, INC.   |  GENECENTRIC DIAGNOSTICS, INC.   |  G1 THERAPEUTICS, INC.   |  LYSOSOMAL THERAPEUTICS, INC.   |  ORIG3N, INC.   |  STRIDEBIO, INC.   |  GENECENTRIC THERAPEUTICS, INC.   |  VIGIL NEUROSCIENCE, INC.   |  PIPR THERAPEUTICS, INC.
CLAY 
B. 
THORP 
DIRECTOR
ARTUSLABS INC   |  HATTERAS VENTURE PARTNERS IV, LP   |  HATTERAS VENTURE PARTNERS V, LP   |  CLEARSIDE BIOMEDICAL, INC.   |  HATTERAS VENTURE PARTNERS VI, LP   |  HATTERAS VENTURE PARTNERS VII, LP   |  HATTERAS OPPORTUNITY FUND I, LP   |  HATTERAS CREATE SF SPV, LLC
DANIEL 
 
WHITE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
TAGNETICS, INC.   |  LOCALVORE, INC.   |  CLEARSIDE BIOMEDICAL, INC.   |  CLEAN CROP TECHNOLOGIES, INC.   |  STAVVY, INC.   |  LANIER BIOTHERAPEUTICS, INC.   |  GABRIEL, ROEDER, SMITH + CO HOLDINGS, INC.   |  CLEARJET INC.   |  GENTIAN TECHNOLOGIES, INC.   |  WALKER-S BLUFF CASINO RESORT, LLC   |  88 TACTICAL, LLC
DANIEL 
H. 
WHITE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
CLEARSIDE BIOMEDICAL, INC.
DEREK 
 
YOON 
DIRECTOR
CLEARSIDE BIOMEDICAL, INC.   |  TREFOIL THERAPEUTICS, INC.   |  ARCELLX, INC.   |  CARBON BIOSCIENCES, INC.   |  EVOLVEIMMUNE THERAPEUTICS HOLDING COMPANY, LLC
EVGENY 
 
ZAYTSEV 
DIRECTOR
ALDEA PHARMACEUTICALS, INC.   |  CLEARSIDE BIOMEDICAL, INC.   |  TRANSCEND MEDICAL INC   |  BERING PARTNERS II, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-12-04
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-11-26 
2016-10-13
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2016-09-28 
2015-12-08
D
Link
OTHER TECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-11-23 
2014-09-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-08-29 
2014-05-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-04-28 
2013-02-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-31 
2012-02-16
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-01-03 
2012-01-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-01-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#